BIRC5 and breast cancer: The transcriptional activities of the CXCR4, survivin, Cox-2, SLPI and EGP-2 promoters driving luciferase expression in recombinant Ad vectors was evaluated in four human breast cancer cell lines (MB-468, AU-565, GI-101 and MB-231).